Hypoxia-inducible Factor-1 Activation in Nonhypoxic Conditions: The Essential Role of Mitochondrial-derived Reactive Oxygen Species
Open accessThe DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a key transcription factor for responses to low oxygen. Different nonhypoxic stimuli, including hormones and growth factors, are also important HIF-1 activators in the vasculature. Angiotensin II (Ang II), the main effecter hormone in the renin-angiotensin system, is a potent HIF-1 activator in vascular smooth muscle cells (VSMCs). HIF-1 activation by Ang II involves intricate mechanisms of HIF-1α transcription, translation, and protein stabilization. Additionally, the generation of reactive oxygen species (ROS) is essential for HIF-1 activation during Ang II treatment. However, the role of the different VSMC ROS generators in HIF-1 activation by Ang II remains unclear. This work aims at elucidating this question. Surprisingly, repression of NADPH oxidase-generated ROS, using Vas2870, a specific inhibitor or a p22 phox siRNA had no significant effect on HIF-1 accumulation by Ang II. In contrast, repression of mitochondrial-generated ROS, by complex III inhibition, by Rieske Fe-S protein siRNA, or by the mitochondrial-targeted antioxidant SkQ1, strikingly blocked HIF-1 accumulation. Furthermore, inhibition of mitochondrial-generated ROS abolished HIF-1α protein stability, HIF-1–dependent transcription and VSMC migration by Ang II. A large number of studies implicate NADPH oxidase–generated ROS in Ang II–mediated signaling pathways in VSMCs. However, our work points to mitochondrial-generated ROS as essential intermediates for HIF-1 activation in nonhypoxic conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We focused our attention on oxidative stress since ROS has been shown to activate HIF1α in several cell models (Patten et al, 2010) and we have shown an enhanced oxidative stress in old control and Mfn2KO mice (Fig 2E).”
From Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway (2016) · cites this paper as Patten et al, 2010
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 2×
“Hypoxia-inducible factor-1 (HIF-1) is a key hypoxia-inducible transcription factor responsible for the adaptation of cells and tissues to low oxygen by regulating such responses as cell metabolism, proliferation and survival, erythropoiesis, and angiogenesis (Semenza, 2003).”
BackgroundMitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084 · cited 3×
“RNA (20 g) was resolved on 1% agarose/6% formaldehyde gels and transferred to Hybond N nylon membranes (GE Healthcare) before hybridization with a radioactive cDNA probes comprising either the total coding sequence of the mouse VEGF gene and the human GLUT1 gene or the 900-base pair coding sequence of the human HIF-1…”
BackgroundInfluentialHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 3×
“A crucial event leading to HIF-1 protein degradation is its binding to the product of the von Hippel-Lindau tumor suppressor gene, pVHL. Binding to pVHL is a direct result of HIF-1 hydroxylation (Ivan et al., 2001).”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 1×
“Molecular Biology of the Cell Vol. 21, 3247–3257, September 15, 2010”
BackgroundNAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886 · cited 2×
“…it was shown that the expression of a dominant negative form of Rac1 can suppress mtROS generation by Ang II (Nozoe et al., 2008) Because Rac1 is required for proper NADPH oxidase assembly, this suggested that the NADPH oxidase is required for increasing mtROS (Griendling et al., 2000).”
BackgroundH 2 O 2 , a Necessary Evil for Cell Signaling
Rhee, S. G. (2006) · Science · doi:10.1126/science.1130481 · Cited by 2,160
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068 · cited 1×
“In hypoxic conditions, low oxygen leads to HIF-1 stabilization due to inhibition of prolyl-hydroxylation and subsequent decreases in HIF-1 ubiquitination and degradation (Cockman et al., 2000; Epstein et al., 2001; Schofield and Ratcliffe, 2004).”
BackgroundChandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000 · cited 1×
“The hypoxic activation of HIF-1 has been shown by two independent groups to be regulated by mtROS (Chandel et al., 2000; Guzy et al., 2005).”
BackgroundMitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545 · cited 1×
“The hypoxic activation of HIF-1 has been shown by two independent groups to be regulated by mtROS (Chandel et al., 2000; Guzy et al., 2005).”
Background
Cited by
Mitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813
Physiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Hypoxia, oxidative stress and inflammation
McGarry, T., Biniecka, M., Veale, D. J., & Fearon, U. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.042 · Cited by 601
Hypoxia-Modified Cancer Cell Metabolism
Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00004 · Cited by 503
Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature
Nguyen Dinh Cat, A., Montezano, A. C., Burger, D., & Touyz, R. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4641 · Cited by 464
Sebastián, D., Sorianello, E., Segalés, J., Irazoki, A., Ruiz‐Bonilla, V., Sala, D., Planet, E., Berenguer‐Llergo, A., Muñoz, J. P., Sánchez‐Feutrie, M., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593084 · Cited by 396
“We focused our attention on oxidative stress since ROS has been shown to activate HIF1 a in several cell models (Patten et al , 2010) The EMBO Journal Mfn 2 deficiency causes sarcopenia and accelerated aging David Sebastián et al”
Mitochondrial ROS regulation of proliferating cells
Diebold, L., & Chandel, N. S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.198 · Cited by 391
“7 mROS production specifically from complex III in vascular smooth muscle cells (VSMC), or targeting mROS with mitochondrial antioxidants resulted in a decrease in HIF stabilization and induction of HIF target gene expression [90].”
BackgroundSuperoxide generation by complex III: From mechanistic rationales to functional consequences
Bleier, L., & Dröse, S. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.12.002 · Cited by 369
Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system
Cho, S. H., Raybuck, A. L., Stengel, K., Wei, M., Beck, T. C., Volanakis, E., Thomas, J. W., Hiebert, S., Haase, V. H., & Boothby, M. R. (2016) · Nature · doi:10.1038/nature19334 · Cited by 309
“Recipients were analyzed after primary (10) immunization or, for memory responses, after the 10 and a recall immunization.”
BackgroundMethodInfluentialGlucose metabolism links astroglial mitochondria to cannabinoid effects
Jimenez-Blasco, D., Busquets-Garcia, A., Hebert-Chatelain, E., Serrat, R., Vicente-Gutierrez, C., Ioannidou, C., Gómez-Sotres, P., Lopez-Fabuel, I., Resch-Beusher, M., Resel, E., et al. (2020) · Nature · doi:10.1038/s41586-020-2470-y · Cited by 271
Broekgaarden, M., Weijer, R., van Gulik, T. M., Hamblin, M. R., & Heger, M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9588-7 · Cited by 255
“HIF-1 activation by ROS HIF-1α stabilization by hypoxiamediated PHD and FIH inactivation can also proceed through ROS-mediated deactivation of PHDs and FIH in a manner that is not necessarily dependent on intracellular oxygen tension [309–311].”
BackgroundMitochondrial redox signalling at a glance
Collins, Y., Chouchani, E. T., James, A. M., Menger, K. E., Cochemé, H. M., & Murphy, M. P. (2012) · Journal of Cell Science · doi:10.1242/jcs.098475 · Cited by 254
“Among the most intriguing is the role of mitochondrial ROS in O2 sensing, especially during hypoxia (Guzy and Schumacker, 2006; Guzy et al., 2008; Patten et al., 2010; Brunelle et al., 2005).”
BackgroundReactive Oxygen Species and Oxidative Stress in Obesity—Recent Findings and Empirical Approaches
McMurray, F., Patten, D. A., & Harper, M. (2016) · Obesity · doi:10.1002/oby.21654 · Cited by 247
“Mitochondrial ROS production, likely at ETC complex III, is responsible for HIF activation in hypoxia and other non-hypoxic stimuli (26-30).”
BackgroundSelf-citationTargeting the Redox Balance in Inflammatory Skin Conditions
Wagener, F., Carels, C., & Lundvig, D. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059126 · Cited by 217
“Also, mitochondrial ROS production is thought to play a role in oxygen sensing via HIF-1 [79,80] under both hypoxic [81] and non-hypoxic conditions [82].”
BackgroundThe role of perivascular adipose tissue in obesity‐induced vascular dysfunction
Xia, N., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13650 · Cited by 206
“Both Ang II and mitoROS are potent activators of HIF-1α (Patten et al., 2010).”
Agharazii, M., St-Louis, R., Gautier-Bastien, A., Ung, R.-V., Mokas, S., Larivière, R., & Richard, D. E. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpu225 · Cited by 180
Self-citationOxidative Stress Under Ambient and Physiological Oxygen Tension in Tissue Culture
Jagannathan, L., Cuddapah, S., & Costa, M. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0050-5 · Cited by 150
“Recent studies show nonhypoxic activation of HIF-1α via mitochondrial-derived ROS [56].”
BackgroundMokas, S., Larivière, R., Lamalice, L., Gobeil, S., Cornfield, D. N., Agharazii, M., & Richard, D. E. (2016) · Kidney International · doi:10.1016/j.kint.2016.05.020 · Cited by 146
Self-citationDiaz, F., Enríquez, J. A., & Moraes, C. T. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06051-11 · Cited by 130
“Hypoxic abrogation of HIF1- stabilization upon knockdown of RISP (15, 50) and the role of ROS (46) have been reported in other cell types also.”
BackgroundThe Interplay Between Respiratory Supercomplexes and ROS in Aging
Genova, M. L., & Lenaz, G. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6214 · Cited by 126
“Nevertheless, the activating effect of ROS on HIF-1 a (22, 152, 308) is still a controversial issue (cf. ROS as signals section).”
InfluentialMitochondrial proticity and ROS signaling: lessons from the uncoupling proteins
Mailloux, R. J., & Harper, M. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.04.004 · Cited by 142
Relationships between LDH-A, Lactate, and Metastases in 4T1 Breast Tumors
Rizwan, A., Serganova, I., Khanin, R., Karabeber, H., Ni, X., Thakur, S., Zakian, K. L., Blasberg, R., & Koutcher, J. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3300 · Cited by 118
Xia, L., Ping, M., Huang, W., Zhang, L., Wang, Y., Zhu, H., Tian, D., Liu, J., Chen, Z., Zhang, Y., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs249 · Cited by 129
“Although current research supports a role for HIF-1 as a prominent regulator of the genetic response to hypoxia, it has recently been shown that certain pro-inflammatory cytokines are able to stabilize HIF-1α and activate HIF-1 (11,12).”
BackgroundLiving on the Edge: ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target
Brandl, N., Seitz, R., Sendtner, N., Müller, M., & Gülow, K. (2025) · Antioxidants · doi:10.3390/antiox14081002 · Cited by 129
“Consequently, HIF-1 α becomes stabilized even in the presence of oxygen, translocates to the nucleus, and activates transcription of adaptive genes [83,126].”
Ježek, P., Jabůrek, M., Holendová, B., Engstová, H., & Dlasková, A. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0173 · Cited by 126
“…the effects of the ablation of Complex III subunits (Bell et al., 2007; Chandel et al., 2000; Chandel et al., 1998; Comito et al., 2011; Guzy et al., 2005; Sabharwal et al., 2013; Schroedl et al., 2002; Waypa et al., 2010) and could be mimicked as a normoxic HIF activation (Patten et al., 2010).”
BackgroundLeon, L. M., Gautier‐Isola, M., Allan, R., Ilié, M., Nottet, N., Pons, N., Paquet, A. C., Lebrigand, K., Truchi, M., Fassy, J., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0935-y · Cited by 124
Lenaz, G., & Genova, M. L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3573-0_5 · Cited by 130
PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1
Requejo-Aguilar, R., López-Fabuel, I., Fernández, E., Martins, L. M., Almeida, Á., & Bolaños, J. P. (2014) · Nature Communications · doi:10.1038/ncomms5514 · Cited by 115
Regulation of life span by mitochondrial respiration: the HIF-1 and ROS connection
Hwang, A. B., & Lee, S.-J. (2011) · Aging · doi:10.18632/aging.100292 · Cited by 108
“Under normoxic conditions, growth factors required for vasculogenesis and cytokines required for the maintenance of hematopoietic stem cells stabilize HIF1, and this stabilization requires ROS [64,65].”
BackgroundMaron, B. A., & Leopold, J. A. (2015) · Circulation · doi:10.1161/circulationaha.114.006980 · Cited by 114
Relevance of Mitochondrial Genetics and Metabolism in Cancer Development
Gasparre, G., Porcelli, A. M., Lenaz, G., & Romeo, G. C. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011411 · Cited by 116
“2010), that are required for proper assembly and activity of mitochondrial complexes (I, III, IV); (3) (further) mtDNA mutations affecting respiratory complexes; and (4) stabilization of HIF1a (Patten et al. 2010).”
BackgroundRedox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics
Ghoneum, A., Abdulfattah, A. Y., Warren, B., Shu, J., & Said, N. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093100 · Cited by 108
Molecular Crosstalk Between MYC and HIF in Cancer
Li, Y., Sun, X.-X., Qian, D. Z., & Dai, M.-S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590576 · Cited by 89
“5 but sometimes survive only until birth due to impaired lung maturation, bradycardia, vascular defects and mitochondrial dysfunction (Tian et al., 1998; Peng et al., 2000; Compernolle et al., 2002).”
BackgroundRedox-mediated signal transduction by cardiovascular Nox NADPH oxidases
Brandes, R. P., Weißmann, N., & Schröder, K. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.006 · Cited by 104
Jan, Y., Lai, T., Yang, C., Lin, Y., Huang, M.-S., & Hsiao, M. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0698-5 · Cited by 106
Calvani, M., Comito, G., Giannoni, E., & Chiarugi, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038388 · Cited by 90
“Mitochondrial ROS have been largely involved in ROS development and consequent HIF-1 stabilization under hypoxia [18], as well as for non hypoxic conditions [19].”
BackgroundReactive Oxygen Species in Vascular Formation and Development
Zhou, Y., Yan, H. M., Guo, M., Zhu, J., Xiao, Q., & Zhang, L. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/374963 · Cited by 103
Key fibrogenic mediators: old players. Renin–angiotensin system
Macconi, D., Remuzzi, G., & Benigni, A. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.11 · Cited by 94
Daijo, H., Hoshino, Y., Kai, S., Suzuki, K., Nishi, K., Matsuo, Y., Harada, H., & Hirota, K. (2016) · Scientific Reports · doi:10.1038/srep34424 · Cited by 95
Mitochondrial Dysfunction: Cause or Consequence of Vascular Calcification?
Phadwal, K., Vrahnas, C., Ganley, I. G., & MacRae, V. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.611922 · Cited by 96
“Increase in ROS levels stabilize and activate HIF-1α, which triggers VSMC transdifferentiation and calcification (Patten et al., 2010; Mokas et al., 2016).”
Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Targets
Zoja, C., Xinaris, C., & Macconi, D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.586892 · Cited by 96
“, 2019; Packer, 2020), a heterodimeric transcription factor that plays a key role in cellular adaptation to different oxygen concentrations (Patten et al., 2010; Packer, 2020).”
BackgroundLi, Y., Xi, M., Guo, Y. C., Hai, C., Yang, W., & Qin, X.-J. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.10.029 · Cited by 89
Pluripotent Stem Cell Metabolism and Mitochondria: Beyond ATP
Lees, J. G., Gardner, D. K., & Harvey, A. J. (2017) · Stem Cells International · doi:10.1155/2017/2874283 · Cited by 78
“This hypothesis is supported by evidence of a prolonged mitochondrial H2O2 presence stabilising HIFα proteins at both physiological [160, 161, 167–169] and atmospheric oxygen conditions [170].”
BackgroundChanmee, T., Ontong, P., Izumikawa, T., Higashide, M., Mochizuki, N., Chokchaitaweesuk, C., Khansai, M., Nakajima, K., Kakizaki, I., Kongtawelert, P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.751263 · Cited by 79
“In addition, reactive oxygen species production has been demonstrated as specifically required for HIF-1 stabilization (30, 31), and a novel mechanism involved in HBP flux has recently been proposed to regulate the stabilization of HIF-1 via changes in protein O-GlcNAcylation (9).”
BackgroundBačenková, D., Trebuňová, M., Demeterová, J., & Živčák, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317096 · Cited by 82
“The production and regulation of reactive oxygen species (ROS) occurs in the mitochondria, and this process is related to hypoxia-inducible factor-1 (HIF-1) [73].”
BackgroundThe Warburg effect modulates DHODH role in ferroptosis: a review
Amos, A., Amos, A., Wu, L., & He, X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01025-9 · Cited by 73
“Genetic and pharmacological inhibition of NADPH oxidase (NOX), a mitochondrial enzyme that produces O2 failed to sustain HIF-1α accumulation under non-hypoxic conditions [49].”
BackgroundHypoxia-inducible factor signaling in the development of kidney fibrosis
Haase, V. H. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s16 · Cited by 77
“When prolyl-4-hydroxylation is inhibited (e.g. by hypoxia, ROS), HIF-a subunits are stabilized and translocate to the nucleus where they heterodimerize with ARNT.”
BackgroundInfluentialLee, Y., Bernstock, J. D., Nagaraja, N., Ko, B., & Hallenbeck, J. M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13643 · Cited by 72
Lee, S.-J., No, Y. R., Dang, D. T., Dang, L. H., Yang, V. W., Shim, H., & Yun, C. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.489708 · Cited by 66
Markovets, A. M., Fursova, A. Z., & Kolosova, N. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021682 · Cited by 65
“Recently, the crucial role of mitochondria-derived ROS for activation HIF-1 was demonstrated and it was shown that the suppression of mitochondrial generation of ROS by SkQ1 effectively blocked HIF-1 accumulation [26].”
BackgroundHome Oxygen in Chronic Obstructive Pulmonary Disease
Lacasse, Y., Tan, A.-Y. M., Maltais, F., & Krishnan, J. A. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201802-0382ci · Cited by 68
Intertwined Relationship of Mitochondrial Metabolism, Gut Microbiome and Exercise Potential
Imdad, S., Lim, W., Kim, J., & Kang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052679 · Cited by 75
“Mt-ROS production can inhibit the activity of PHDs to increase HIF-1α, in hypoxic as well as normoxic conditions [215,216].”
BackgroundModulation of Vascular Reactivity by Perivascular Adipose Tissue (PVAT)
Rosei, C. A., Paini, A., Ciuceis, C. D., Withers, S., Greenstein, A. S., Heagerty, A. M., & Rizzoni, D. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0835-5 · Cited by 66
Redox Signaling from Mitochondria: Signal Propagation and Its Targets
Ježek, P., Holendová, B., & Plecitá‐Hlavatá, L. (2020) · Biomolecules · doi:10.3390/biom10010093 · Cited by 63
“A similar hypoxic ROS burst was reported to occur even during normoxic HIF activation [176].”
BackgroundZhang, C., Liu, Q., Li, M., Lin, S., Peng, Y., Wu, D., Li, T. Y., Fu, Q., Jia, W., Wang, X., et al. (2015) · Cell Research · doi:10.1038/cr.2015.90 · Cited by 62
Vosloo, A., Laas, A., & Vosloo, D. (2012) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2012.09.002 · Cited by 59
“The upregulation ofHcunder hyperoxic conditions can also be explained by a HIF-mediated transcriptional activation, asmitochondrial ROS have been shown to stabilize HIF-1α and consequently activate HIF-dependent downstream genes under non-hypoxic conditions (Patten et al., 2010).”
BackgroundIntegration of superoxide formation and cristae morphology for mitochondrial redox signaling
Plecitá‐Hlavatá, L., & Ježek, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.010 · Cited by 60
Zhou, B., Caudal, A., Tang, X., Chavez, J. D., McMillen, T. S., Keller, A., Villet, O. M., Zhao, M., Liu, Y., Ritterhoff, J., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155333 · Cited by 55
Mitochondria-targeted Resveratrol Derivatives Act as Cytotoxic Pro-oxidants
Nicola Sassi, A., Mattarei, A., Azzolini, M., Bernardi, P., Szabó, I., Paradisi, C., Zoratti, M., & Biasutto, L. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990034 · Cited by 57
“Mitochondrial ROS are involved in the activation of Hypoxia Inducible Factor (HIF) [9], which influences angiogenesis and other aspects of tumor growth [10].”
Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases
Pérez-Araluce, M., Jüngst, T., Sanmartín, C., Prósper, F., Plano, D., & Mazo, M. M. (2024) · Biomimetics · doi:10.3390/biomimetics9010023 · Cited by 58
“For instance, they play a crucial role in activating hypoxia-inducible factors (HIFs) [5], which, in turn, induce the expression of erythropoietin (EPO) to boost red blood cell production, vascular endothelial growth factor (VEGF) to stimulate angiogenesis and glycolytic enzymes to maintain ATP…”
BackgroundLoveikyte, R., Bourgonje, A. R., van Goor, H., Dijkstra, G. D. H., & Jong, A. E. V. D. M. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102950 · Cited by 54
“Additionally, studies have suggested that ROS itself can stabilize HIF-1 ⍺ that, in turn, promotes glycolysis in non-hypoxic conditions and generates more ROS, creating a vicious cycle [37].”
BackgroundBrightness and shadows of mitochondrial ROS in the brain
Jiménez-Blasco, D., Almeida, Á., & Bolaños, J. P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106199 · Cited by 61
“This leads to decreased mROS generation that results in loss of activation of hypoxiainducible factor-1α (HIF1α), known to be stabilized by ROS to promote the transcriptional activity of HIF1 (Patten et al., 2010).”
BackgroundKlotho Ameliorates Medullary Fibrosis and Pressure Natriuresis in Hypertensive Rat Kidneys
Takenaka, T., Inoue, T., Miyazaki, T., Kobori, H., Nishiyama, A., Ishii, N., Hayashi, M., & Suzuki, H. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11176 · Cited by 51
Redox Molecular Machines Involved in Tumor Progression
Parri, M., & Chiarugi, P. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5040 · Cited by 47
Transcriptional Regulation of Yeast Oxidative Phosphorylation Hypoxic Genes by Oxidative Stress
Liu, J., & Barrientos, A. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4589 · Cited by 54
“…hypoxia inducing factor 1 (HIF-1) complex, a transcriptional activator that functions as a master regulator of oxygen homeostasis in all metazoan species, has been shown to be activated by nonhypoxic stimuli involving mitochondria-generated ROS as essential signaling intermediates (22, 24, 27, 36).”
Lafleur, V. N., Richard, S., & Richard, D. E. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0423 · Cited by 52
“Under these conditions, changes in HIF-1α half-life reflect changes in HIF-1α stability (Laughner et al., 2001; Page et al., 2008; Michaud et al., 2009; Patten et al., 2010; Labbe et al., 2012). siPRMT1- or siCtrl-transfected cells were maintained under hypoxic conditions for 1 h to induce HIF-1α.”
BackgroundSelf-citationShan, F., Huang, Z., Xiong, R., Huang, Q., & Li, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28953 · Cited by 47
“Accumulating evidence depicted a master role of HIF1 in VSMCs functions in response to hypoxia (Patten et al., 2010).”
BackgroundMetabolic Messengers: endocannabinoids
Busquets-García, A., Bolaños, J. P., & Marsicano, G. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00600-1 · Cited by 50
Iacobini, C., Vitale, M., Haxhi, J., Pesce, C. M., Pugliese, G., & Menini, S. (2022) · Antioxidants · doi:10.3390/antiox11112183 · Cited by 47
Wang, Y., Yang, J., Yang, K., Cang, H., Huang, X., Li, H., & Yi, J. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.40 · Cited by 45
Kotarsky, H., Keller, M., Davoudi, M., Levéen, P., Karikoski, R., Enot, D. P., & Fellman, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041156 · Cited by 43
“In contrast to findings in fibroblasts harbouring other CIII deficiencies [7,16,17] no elevated H2O2 levels could be detected in liver mitochondria from Bcs1lG/G mice.”
InfluentialCurbing cancer's sweet tooth: Is there a role for MnSOD in regulation of the Warburg effect?
Holley, A. K., Dhar, S. K., & Clair, D. K. S. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.07.104 · Cited by 41
“Loss of mtDNA or expression of catalase abrogated hypoxia-induced activation of HIF-1 (Chandel et al., 2000; Guzy et al., 2005; Patten et al., 2010).”
Hypoxia decreases ROS level in human fibroblasts
Sgarbi, G., Gorini, G., Costanzini, A., Barbato, S., Solaini, G., & Baracca, A. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.05.005 · Cited by 42
“…prolyl hydroxylase) (King et al., 2006), but also by pyruvate and oxaloacetate (Lu et al., 2005; McFate et al., 2008) and, interestingly, by ROS (Hamanaka and Chandel, 2009, 2010; Patten et al., 2010), although the activating effect of ROS on HIFs is a controversial issue (Bell et al., 2008).”
BackgroundRiou, M., Enache, I., Sauer, F., Charles, A., & Gény, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119572 · Cited by 38
“Mitochondrial ROS could also modulate HIF-1 α expression [11,12].”
BackgroundResveratrol binds and inhibits transcription factor HIF-1α in pancreatic cancer
Srivani, G., Behera, S. K., Dariya, B., Aliya, S., Alam, A., & Nagaraju, G. P. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112126 · Cited by 38
Li, X., Xing, J., Wang, H., & Yu, E. (2018) · Bioscience Reports · doi:10.1042/bsr20180268 · Cited by 38
“Several studies have demonstrated that HIF-1 α stabilization is regulated by ROS [16].”
Wyss, C. B., Duffey, N., Peyvandi, S., Barras, D., Martínez-Usatorre, A., Coquoz, O., Romero, P. J., Delorenzi, M., Lorusso, G., & Rüegg, C. (2021) · Cancer Research · doi:10.1158/0008-5472.can-19-3560 · Cited by 36
Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Skulachev, V. P. (2015) · Frontiers in bioscience · doi:10.2741/4343 · Cited by 36
“As shown by our and some other groups, the antioxidant properties of SkQ1 are due to its direct ROS scavenging activity [23, 24, 26, 34].”
BackgroundImproving the Efficacy of Plant Polyphenols
Biasutto, L., Mattarei, A., Nicola Sassi, A., Azzolini, M., Romio, M., Paradisi, C., & Zoratti, M. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520614666140627150054 · Cited by 36
Role of HIF-1α in Alcohol-Mediated Multiple Organ Dysfunction
Morris, N. L., & Yeligar, S. M. (2018) · Biomolecules · doi:10.3390/biom8040170 · Cited by 35
Sun, H., Li, X., Chen, X., Xiong, Y., Cao, Y., & Wang, Z. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02542-7 · Cited by 46
“Additionally, a prior study has verified that the generation of ROS leads to HIF-1 activation [20].”
BackgroundPark, S. J., Lee, K. S., Lee, S. J., Kim, S. R., Park, S. Y., Jeon, M. S., Lee, H. B., & Lee, Y. C. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13077915 · Cited by 34
“Recent reports have demonstrated a potential role of HIF-1 induction in vascular remodeling [36] and ROS as essential intermediates for HIF signaling in non-hypoxic conditions [37].”
BackgroundRedox imbalance and hypoxia‐inducible factors: a multifaceted crosstalk
Ravi, R., & Singh, J. (2025) · FEBS Journal · doi:10.1111/febs.70013 · Cited by 33
Free Radical Medicine and Biology
Das, K. K., Das, S. N., Biradar, M. S., Bobbarala, V., & Tata, S. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77829 · Cited by 31
Rosei, C. A., Withers, S., Belcaid, L., Ciuceis, C. D., Rizzoni, D., & Heagerty, A. M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000506 · Cited by 31
“In addition, it has been demonstrated that in vascular smooth muscle cells, Ang II is a potent activator of HIF-1a by common as well as different mechanisms from hypoxia [16,17].”
BackgroundInfluentialYang, J., Chuang, Y.-C., Tseng, J., Liu, Y., Lai, C.-Y., Lee, A. Y., Huang, C. F., Hong, Y., & Chuang, T. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03094-9 · Cited by 31
“Reactive oxygen species and succinate have been shown to increase the stabilization and activation of hypoxia-inducible factor 1α (HIF-1α) by inactivating prolyl hydroxylases (PHD) [15, 16, 24, 25].”
BackgroundResultKimura, K., Jackson, T. L. B., & Huang, R. C. C. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110580 · Cited by 30
“An increased level of ROS in the mitochondria leads to the stabilization and accumulation of HIF1A by inhibiting prolyl hydroxylase under normoxic conditions [122,123].”
The Werner syndrome gene product (WRN): a repressor of hypoxia-inducible factor-1 activity
Labbé, A., Lafleur, V. N., Patten, D. A., Robitaille, G., Garand, C., Lamalice, L., Lebel, M., & Richard, D. E. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.04.010 · Cited by 30
“Our previous studies showed that increased mtROS led to decreased cellular ascorbate levels, decreased hydroxylase activity and increased HIF-1a stability and accumulation [37].”
BackgroundSelf-citationYun, C. C. (2019) · Cancers · doi:10.3390/cancers11070958 · Cited by 28
“HIF-1α is a transcription factor that mediates adaptive responses to changes in tissue oxygenation, but several growth factors, activated oncogenes, and LPA can induce HIF-1α expression under nonhypoxic conditions [148,149].”
BackgroundBranched-chain α-ketoacids aerobically activate HIF1α signalling in vascular cells
Xiao, W., Shrimali, N. M., Vigder, N., Oldham, W. M., Clish, C. B., He, H., Wong, S. J., Wertheim, B. M., Arons, E., Haigis, M. C., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01150-4 · Cited by 29
Chen, L., Chen, M., Yang, X., Hu, Y., Qiu, C., Fu, Y., Lan, X., Luo, G., Liu, Q., & Liu, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1617305 · Cited by 28
Zhou, Q., Meng, G., Teng, F., Sun, Q., & Zhang, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26243 · Cited by 26
“Astragalus polysaccharide (APS), one of the main active ingredients of astragalus, can function as an immune enhancer or modifier, which has anti-inflammatory, anti-oxidation, anti-aging, anti-viral, and anti-tumor effects.8 APS has an important effect for improving the myocardial hypertrophy and diabetic cardiomyopat…”
BackgroundInfluentialRetractedBiswas, S., Mukherjee, R., Tapryal, N., Singh, A. K., & Mukhopadhyay, C. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062128 · Cited by 28
“angiotensin II [16,24,30], IGF-1 [23] and transition metals [15,25]; whereas, H2O2 or lipopolysaccharide (LPS) treatment promotes NF-kB mediated HIF-1a transcription for HIF-1 activation [26,39].”
BackgroundInfluentialNath, M., Chandra, P., Halder, N., Singh, B., Deorari, A. K., Kumar, A., Azad, R., & Velpandian, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168809 · Cited by 24
Anwar, M. R., Saldana-Caboverde, A., García, S., & Díaz, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061582 · Cited by 27
“CI, CII and CIII are the most prominent sites of free radical production [32].”
BackgroundXie, Z., Chen, J., Wang, C., Zhang, J., Wu, Y., & Yan, X. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa080 · Cited by 24
Sun, T., Zhang, X., Hou, C., Yu, S., Zhang, Y., Yu, Z., Kong, L., Liu, C., Feng, L., Wang, D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941219 · Cited by 32
“It has been found that mitochondrial-derived ROS is a non-hypoxic factor for HIF-1a stabilization and HIF-1 activation (49, 50).”
BackgroundHypoxia Pathways in Parkinson’s Disease: From Pathogenesis to Therapeutic Targets
Gao, Y., Zhang, J., Tang, T., & Liu, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910484 · Cited by 23
“Inhibition of mitochondrial ROS can eliminate Ang II-induced HIF-1 protein stability, HIF-1-dependent transcription, and VSMC migration [137].”
BackgroundPhysiological Functions of Mitochondrial Reactive Oxygen Species
Choi, T. G., & Kim, S. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88386 · Cited by 23
Huynh, N. T., Beutler, J. A., Shulkes, A., Baldwin, G. S., & He, H. Z. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.10.013 · Cited by 25
Metadata
- Authors
- Patten, D. A., Lafleur, V. N., Robitaille, G. A., Chan, D. A., Giaccia, A. J., & Richard, D. E.
- Affiliations
- Centre hospitalier universitaire de Québec (CA)
- Stanford Medicine (US)
- Corresponding author
- Richard, Darren E.
- Venue
- Molecular Biology of the Cell
- Published
- 2010-09-15
- Volume
- 21
- Issue
- 18
- Pages
- 3247-3257
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC2938389
- OpenAlex
- W2165725371
- Cited by
- 171
- References
- 78
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 13 · 2023: 16 · 2022: 22 · 2021: 6 · 2020: 11 · 2019: 11 · 2018: 9 · 2017: 6 · 2016: 12 · 2015: 11 · 2014: 10 · 2013: 13 · 2012: 19
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- Molecular Biology of the Cell (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- Funders
- Canadian Institutes of Health Research (102760_1, MOP-49609)
- National Cancer Institute (R37CA088480)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- HIF-1, HIF-1α stabilization, angiotensin II, vascular smooth muscle cells, mitochondrial reactive oxygen species, NADPH oxidase, complex III inhibition, Rieske iron-sulfur protein, SkQ1, cell migration, renin-angiotensin system
- MeSH terms
- Angiotensin II, Animals, Anti-Bacterial Agents, Antifungal Agents, Cells, Cultured, Male, Methacrylates, Mitochondria, Muscle, Smooth, Vascular, Polyenes, Thiazoles, Electron Transport Complex III, Rats, Wistar, Reactive Oxygen Species, NADPH Oxidases, Mitogen-Activated Protein Kinase 1, Myocytes, Smooth Muscle, RNA, Small Interfering, Mitogen-Activated Protein Kinase 3, Rats, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.